| Primary |
| Hyperprolactinaemia |
23.9% |
| Prolactinoma |
19.0% |
| Pituitary Tumour Benign |
14.4% |
| Blood Prolactin Increased |
8.0% |
| Lactation Inhibition Therapy |
6.5% |
| Pituitary Tumour |
6.3% |
| Adenoma Benign |
3.4% |
| Suppressed Lactation |
2.7% |
| Hypertension |
2.0% |
| In Vitro Fertilisation |
2.0% |
| Prolactin-producing Pituitary Tumour |
1.7% |
| Blood Prolactin Abnormal |
1.5% |
| Hypothyroidism |
1.2% |
| Ill-defined Disorder |
1.2% |
| Blood Cholesterol Increased |
1.0% |
| Drug Use For Unknown Indication |
1.0% |
| Hypopituitarism |
1.0% |
| Mental Disorder |
1.0% |
| Overdose |
1.0% |
| Secretory Adenoma Of Pituitary |
1.0% |
|
| Blood Prolactin Increased |
9.7% |
| Weight Increased |
9.1% |
| Vomiting |
8.4% |
| Nausea |
6.5% |
| Syncope |
6.5% |
| Tachycardia |
6.5% |
| Abortion Spontaneous |
4.5% |
| Pituitary Tumour Benign |
4.5% |
| Pregnancy |
4.5% |
| Visual Acuity Reduced |
4.5% |
| Pituitary Tumour Recurrent |
3.9% |
| Tremor |
3.9% |
| Vertigo |
3.9% |
| Weight Decreased |
3.9% |
| Colitis Ischaemic |
3.2% |
| Drug Ineffective |
3.2% |
| Dyspnoea |
3.2% |
| Osteoarthritis |
3.2% |
| Pain |
3.2% |
| Raynaud's Phenomenon |
3.2% |
|
| Secondary |
| Depression |
22.4% |
| Personality Disorder |
21.9% |
| Hyperprolactinaemia |
10.7% |
| Pituitary Tumour Benign |
7.3% |
| Prolactinoma |
6.1% |
| Blood Prolactin Increased |
5.6% |
| Acromegaly |
5.4% |
| Adenoma Benign |
2.9% |
| Pituitary Tumour |
2.4% |
| In Vitro Fertilisation |
1.9% |
| Hypertension |
1.7% |
| Mental Disorder |
1.7% |
| Product Used For Unknown Indication |
1.7% |
| Amenorrhoea |
1.5% |
| Lactation Inhibition Therapy |
1.5% |
| Overdose |
1.5% |
| Blood Cholesterol Increased |
1.0% |
| Epilepsy |
1.0% |
| Schizophrenia |
1.0% |
| Secretory Adenoma Of Pituitary |
1.0% |
|
| Epistaxis |
14.9% |
| Blood Prolactin Increased |
9.0% |
| Self Injurious Behaviour |
9.0% |
| Abortion Spontaneous |
7.5% |
| Visual Acuity Reduced |
7.5% |
| Nausea |
6.0% |
| Osteoarthritis |
4.5% |
| Poor Quality Drug Administered |
4.5% |
| Presyncope |
4.5% |
| Antepartum Haemorrhage |
3.0% |
| Bleeding Peripartum |
3.0% |
| Galactorrhoea |
3.0% |
| Liver Function Test Abnormal |
3.0% |
| Menstruation Delayed |
3.0% |
| Neoplasm Progression |
3.0% |
| Pancreatitis |
3.0% |
| Pancreatitis Acute |
3.0% |
| Pituitary Tumour |
3.0% |
| Product Counterfeit |
3.0% |
| Pruritus Generalised |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.7% |
| Acromegaly |
15.0% |
| Hypertension |
7.9% |
| Drug Use For Unknown Indication |
6.1% |
| Pain |
5.5% |
| Diabetes Mellitus |
4.5% |
| Pituitary Tumour Benign |
4.3% |
| Hiv Infection |
3.6% |
| Neuropathy Peripheral |
3.4% |
| Depression |
3.0% |
| Prostate Cancer |
3.0% |
| Hypopituitarism |
2.8% |
| Hypothyroidism |
2.6% |
| Prophylaxis |
2.6% |
| Blood Corticotrophin Decreased |
2.0% |
| Growth Hormone Deficiency |
2.0% |
| Blood Follicle Stimulating Hormone Decreased |
1.8% |
| Primary Hypothyroidism |
1.8% |
| Acute Psychosis |
1.6% |
| Bipolar Disorder |
1.6% |
|
| Weight Decreased |
9.3% |
| Wound |
8.1% |
| Syncope |
7.0% |
| Heart Rate Decreased |
5.8% |
| Malignant Melanoma |
5.8% |
| Vomiting |
5.8% |
| Hypotension |
4.7% |
| Metastatic Malignant Melanoma |
4.7% |
| Ovarian Hyperstimulation Syndrome |
4.7% |
| Subdural Haematoma |
4.7% |
| Thrombocytopenia |
4.7% |
| Tremor |
4.7% |
| Type 2 Diabetes Mellitus |
4.7% |
| Weight Increased |
4.7% |
| Anxiety |
3.5% |
| Brain Stem Haemorrhage |
3.5% |
| Diabetes Mellitus |
3.5% |
| Dyspnoea |
3.5% |
| Hypertransaminasaemia |
3.5% |
| Malaise |
3.5% |
|
| Interacting |
| Diabetes Mellitus |
21.1% |
| Depression |
15.8% |
| Hyperprolactinaemia |
15.8% |
| Renal Transplant |
15.8% |
| Hypertension |
10.5% |
| Blood Cholesterol |
5.3% |
| Hypothyroidism |
5.3% |
| Pain |
5.3% |
| Pituitary Tumour Benign |
5.3% |
|
| Tenderness |
75.0% |
| Pain In Extremity |
25.0% |
|
